No Data
No Data
Craig-Hallum Maintains Repligen(RGEN.US) With Buy Rating
Repligen Corporation's (NASDAQ:RGEN) Intrinsic Value Is Potentially 80% Above Its Share Price
Earnings Preview: Repligen to Report Financial Results Pre-market on February 20
Craig-Hallum Initiates Repligen(RGEN.US) With Buy Rating
Market Participants Recognise Repligen Corporation's (NASDAQ:RGEN) Revenues
Fund Update: SEGALL BRYANT & HAMILL, LLC Opened a $19.0M Position in $RGEN Stock